IBI343 in Combination Therapy for Advanced Malignant Solid Tumors

Clinical trial NCT07483554 · RECRUITING

Trial details

NCT number: NCT07483554
Sponsor: Innovent Biologics (Suzhou) Co. Ltd.
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

CLDN18.2 Positive Gastric/Gastroesophageal Junction Adenocarcinoma Pancreatic Ductal Adenocarcinoma

Start date: 2026-04-20
Primary completion: 2028-03-31
Enrollment: 389

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.